buthionine sulfoximine has been researched along with Friedreich Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Richardson, TE; Simpkins, JW; Wen, Y; Yang, SH | 1 |
| Richardson, TE; Simpkins, JW; Wen, Y; Yang, SH; Yu, AE | 1 |
| Richardson, TE; Simpkins, JW | 1 |
| Antenora, A; Brescia Morra, V; De Michele, G; Filla, A; Marsili, A; Nesti, C; Pane, C; Puorro, G; Saccà, F; Santorelli, FM; Scoppettuolo, P; Tessa, A | 1 |
4 other study(ies) available for buthionine sulfoximine and Friedreich Disease
| Article | Year |
|---|---|
Estrogen protection in Friedreich's ataxia skin fibroblasts.
Topics: Adult; Antioxidants; Buthionine Sulfoximine; Cell Survival; Cells, Cultured; Estradiol; Estrogen Receptor Modulators; Estrogens; Fibroblasts; Friedreich Ataxia; Glutathione; Humans; Male; Neuroprotective Agents; Oxidative Stress; Phenols; Reactive Oxygen Species; Receptors, Estrogen; Receptors, G-Protein-Coupled; Skin; Structure-Activity Relationship | 2011 |
Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts.
Topics: Aconitate Hydratase; Adenosine Triphosphate; Adult; Buthionine Sulfoximine; Cell Death; Cell Respiration; Cell Survival; Cytoprotection; Estrogen Receptor beta; Estrogens; Fibroblasts; Friedreich Ataxia; Gene Expression Regulation; Glutathione; Humans; Lipid Peroxidation; Membrane Potential, Mitochondrial; Mitochondria; Oxidative Stress; Reactive Oxygen Species; Skin | 2012 |
R- and S-equol have equivalent cytoprotective effects in Friedreich's ataxia.
Topics: Adult; Buthionine Sulfoximine; Cell Survival; Cells, Cultured; Cytoprotection; Equol; Estradiol; Estrogens; Fibroblasts; Friedreich Ataxia; Humans; Oxidative Stress; Protective Agents; Reactive Oxygen Species | 2012 |
Clinical use of frataxin measurement in a patient with a novel deletion in the FXN gene.
Topics: Analysis of Variance; Antimetabolites; Buthionine Sulfoximine; Cell Line, Transformed; Family Health; Female; Frataxin; Friedreich Ataxia; Genetic Testing; Humans; Iron-Binding Proteins; Lymphocytes; Male; Middle Aged; RNA, Messenger; Sequence Deletion; Severity of Illness Index; Trinucleotide Repeat Expansion; Young Adult | 2013 |